Related Experiment Video
Updated: Jun 15, 2026

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease
Published on: December 20, 2017
PQ interval in patients with Fabry disease
Mehdi Namdar1, Christoph Kampmann, Jan Steffel
1Clinic for Cardiology, University Hospital of Zurich, Zurich, Switzerland. mehdi.namdar@usz.ch
Shortening of the PQ interval is uncommon in newly diagnosed Fabry disease (FD). This electrocardiographic finding showed no correlation with cardiac abnormalities seen on echocardiograms in FD patients.
Area of Science:
- Cardiology
- Genetics
- Biochemistry
Background:
- Fabry disease (FD) is an X-linked lysosomal storage disorder.
- Cardiac involvement, particularly left ventricular hypertrophy, is common in FD.
- Atrioventricular (AV) conduction abnormalities can also occur in FD.
Purpose of the Study:
- To analyze atrioventricular conduction abnormalities on baseline electrocardiograms in FD patients.
- To investigate the correlation between electrocardiographic findings and echocardiographic parameters in FD.
Main Methods:
- Electrocardiograms (ECGs) of 207 FD patients were analyzed.
- ECG findings were compared with echocardiographic data.
- Analysis included PQ interval, AV block, left ventricular hypertrophy, and atrial size.
Main Results:
- PQ-interval shortening was found in 14% of patients; first-degree AV block in 1.4%.
- No significant echocardiographic differences were observed between patients with or without PQ-interval shortening.
- No correlation was detected between PQ interval and echocardiographic parameters.
Conclusions:
- Shortening of the PQ interval is not a frequent electrocardiographic finding in newly diagnosed FD.
- Baseline ECG findings, specifically PQ interval, do not correlate with echocardiographic parameters or disease stage in FD.
More Related Videos
05:56Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
Published on: August 29, 2025
04:48Noninvasive Determination of Vortex Formation Time Using Transesophageal Echocardiography During Cardiac Surgery
Published on: November 28, 2018
Related Concept Videos
Dysrhythmias IV: Characteristics of Bradyarrhythmias
Mitral Stenosis II: Clinical features and Diagnostic Tests
Acute Coronary Syndrome III: Diagnostic Studies
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):